Purity | Size | Price | VIP Price | USA Stock *0-1 Day | Global Stock *5-7 Days | Quantity | |||||
{[ item.p_purity ]} | {[ item.pr_size ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} |
{[ getRatePrice(item.pr_usd, 1,1) ]} | Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate) ]} {[ getRatePrice(item.pr_usd,1,item.mem_rate) ]} | {[ item.pr_usastock ]} | Inquiry - | {[ item.pr_chinastock ]} | Inquiry - |
* Storage: {[proInfo.prStorage]}
CAS No. : | 71933-03-4 | MDL No. : | MFCD09754091 |
Formula : | C6H5BrN2O3 | Boiling Point : | - |
Linear Structure Formula : | - | InChI Key : | LQTKGJRZBOYLEY-UHFFFAOYSA-N |
M.W : | 233.02 | Pubchem ID : | 33698120 |
Synonyms : |
|
Num. heavy atoms : | 12 |
Num. arom. heavy atoms : | 6 |
Fraction Csp3 : | 0.17 |
Num. rotatable bonds : | 2 |
Num. H-bond acceptors : | 5.0 |
Num. H-bond donors : | 1.0 |
Molar Refractivity : | 43.03 |
TPSA : | 72.31 Ų |
GI absorption : | High |
BBB permeant : | No |
P-gp substrate : | No |
CYP1A2 inhibitor : | No |
CYP2C19 inhibitor : | No |
CYP2C9 inhibitor : | No |
CYP2D6 inhibitor : | No |
CYP3A4 inhibitor : | No |
Log Kp (skin permeation) : | -6.97 cm/s |
Log Po/w (iLOGP) : | 1.37 |
Log Po/w (XLOGP3) : | 1.06 |
Log Po/w (WLOGP) : | 0.73 |
Log Po/w (MLOGP) : | 0.16 |
Log Po/w (SILICOS-IT) : | 0.96 |
Consensus Log Po/w : | 0.86 |
Lipinski : | 0.0 |
Ghose : | None |
Veber : | 0.0 |
Egan : | 0.0 |
Muegge : | 0.0 |
Bioavailability Score : | 0.55 |
Log S (ESOL) : | -2.19 |
Solubility : | 1.5 mg/ml ; 0.00645 mol/l |
Class : | Soluble |
Log S (Ali) : | -2.17 |
Solubility : | 1.58 mg/ml ; 0.00677 mol/l |
Class : | Soluble |
Log S (SILICOS-IT) : | -2.01 |
Solubility : | 2.26 mg/ml ; 0.00968 mol/l |
Class : | Soluble |
PAINS : | 0.0 alert |
Brenk : | 0.0 alert |
Leadlikeness : | 1.0 |
Synthetic accessibility : | 2.08 |
Signal Word: | Warning | Class: | N/A |
Precautionary Statements: | P261-P305+P351+P338 | UN#: | N/A |
Hazard Statements: | H302-H315-H319-H335 | Packing Group: | N/A |
GHS Pictogram: |
* All experimental methods are cited from the reference, please refer to the original source for details. We do not guarantee the accuracy of the content in the reference.
[ 1009826-93-0 ]
Methyl 5-bromopyrimidine-4-carboxylate
Similarity: 0.90
[ 1034737-23-9 ]
Methyl 2-amino-5-bromopyrimidine-4-carboxylate
Similarity: 0.86
[ 64224-60-8 ]
5-Bromo-4-pyrimidinecarboxylic acid
Similarity: 0.82
[ 914208-48-3 ]
2-Amino-5-bromopyrimidine-4-carboxylic acid
Similarity: 0.78
[ 100707-39-9 ]
2-Methyl-5-bromopyrimidine-4-carboxylic acid
Similarity: 0.78
[ 70662-93-0 ]
Methyl 5-chloro-2-oxo-2,3-dihydropyrimidine-4-carboxylate
Similarity: 0.70
[ 878158-18-0 ]
Methyl 5,6-dihydroxy-2-methylpyrimidine-4-carboxylate
Similarity: 0.63
[ 944317-70-8 ]
(5-Bromo-2-(methylthio)pyrimidin-4-yl)methanol
Similarity: 0.59
[ 1036755-95-9 ]
Methyl 2-oxo-1,2-dihydroquinazoline-6-carboxylate
Similarity: 0.57
[ 858956-25-9 ]
2-Cyclopropyl-6-hydroxypyrimidine-4-carboxylic acid
Similarity: 0.57
[ 1009826-93-0 ]
Methyl 5-bromopyrimidine-4-carboxylate
Similarity: 0.90
[ 1034737-23-9 ]
Methyl 2-amino-5-bromopyrimidine-4-carboxylate
Similarity: 0.86
[ 50593-91-4 ]
Methyl 5-bromo-2-(methylthio)pyrimidine-4-carboxylate
Similarity: 0.76
[ 70662-93-0 ]
Methyl 5-chloro-2-oxo-2,3-dihydropyrimidine-4-carboxylate
Similarity: 0.70
[ 1009826-93-0 ]
Methyl 5-bromopyrimidine-4-carboxylate
Similarity: 0.90
[ 1034737-23-9 ]
Methyl 2-amino-5-bromopyrimidine-4-carboxylate
Similarity: 0.86
[ 64224-60-8 ]
5-Bromo-4-pyrimidinecarboxylic acid
Similarity: 0.82
[ 914208-48-3 ]
2-Amino-5-bromopyrimidine-4-carboxylic acid
Similarity: 0.78
[ 100707-39-9 ]
2-Methyl-5-bromopyrimidine-4-carboxylic acid
Similarity: 0.78